Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.440
-0.040 (-0.89%)
At close: Dec 12, 2025, 4:00 PM EST
4.430
-0.010 (-0.23%)
After-hours: Dec 12, 2025, 5:52 PM EST
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $251.09 million as of December 12, 2025. Its market cap has decreased by -39.94% in one year.
Market Cap
251.09M
Enterprise Value
93.34M
1-Year Change
-39.94%
Ranking
Category
Stock Price
$4.44
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $251.09M, a decrease of -55.59%. That is a compound annual growth rate of -14.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 251.09M | -4.31% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |